Introduction
Cervical cancer is one of the most common gynecological malignancies worldwide, with a global incidence of approximately 500,000 new diagnosed cases and 260,000 cases of cancer-related deaths annually. 1 The morbidity and mortality of cervical cancer tend to drop over the last 30 years in many countries due to the effectiveness of widespread implementation of Pap smear screening tests. 2 However, the prognosis of advanced patients with cervical cancer still remains poor, and the 5-year survival rate at the late stages is approximately as low as 15%. 3, 4 Therefore, it is urgently needed to identify novel prognostic markers and better understand the molecular mechanisms underlying the initiation and development of cervical cancer. been illustrated in multiple cancers including cervical cancer. 6, 7 LncRNAs are generally defined as RNA transcripts with more than 200 nucleotides in length and no proteincoding potential. Increasing evidence has indicated that lncRNAs are implicated in a variety of pathophysiological processes, such as gene expression, cell proliferation, apoptosis, and tumorigenesis. 8 Importantly, lncRNA was found to function as either oncogene or anti-oncogene to participate in the pathogenesis and development of many kinds of diseases including cancers. 9 Growth arrest special 5 (GAS5), located at 1q25 locus which is associated with lymphoma, 10 is an lncRNA initially extracted from mouse NIH 3T3 cells using subtraction hybridization. 11 Several studies showed that GAS5 was downregulated and served as a tumor suppressor in many kinds of cancers, such as breast cancer, prostate cancer, and lung cancer. [12] [13] [14] In addition, GAS5 was downregulated in cervical cancer tissues and knockdown of GAS5 promoted proliferation, migration, and invasion in cervical cancer cells. 15 Recently, a competing endogenous RNA (ceRNA) regulatory network has revealed that lncRNA function as a molecular sponge in regulating the expression and biological functions of miRNAs. 16 However, the underlying mechanism of GAS5 involved in the ceRNA regulatory network in cervical cancer remains unknown. By bioinformatics-based target prediction analysis, GAS5 was found to be a molecular sponge of miR-196a and miR-205. A previous study reported that miR-196a was upregulated and miR-196a overexpression improved G1/S phase and proliferation ability of cervical cancer cells, while inhibition of miR-196a displayed the opposite effect. 17 In addition, miR-205 was revealed to be highly expressed and promotes proliferation and migration in human cervical cancer cells. 18 Therefore, we hypothesized that GAS5 might participate in the regulation of cervical cancer development by sponging miR-196a and miR-205.
In this study, we aimed to determine the biological role of GAS5 in cervical cancer and further explore whether GAS5 exert anti-cancer properties by sponging miR-196a and miR-205 in cervical cancer.
Materials and methods

Patient samples
Cervical cancer tissues and adjacent normal tissues were obtained from 41 cervical cancer patients undergoing hysterectomy at Renmin Hospital of Wuhan University (Wuhan, China). Patients included in this study received neither radiotherapy nor chemotherapy before the operation. All fresh specimens were immediately placed in liquid nitrogen following surgical resection and maintained at −80°C until RNA extraction. The confirmation of cervical cancer tissues or normal tissues was determined by pathologic examination. This study protocol was approved by the Institutional Research Ethics Committee of our hospital, and informed consent was obtained from all patients prior to tissue collection.
Cell lines and culture condition
Human cervical cancer cell lines (SiHa, HT-3, SW756, and ME-180) were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). All cells were grown in RPMI-1640 medium (Gibco, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) in a humidified atmosphere containing 5% CO 2 at 37°C.
Cell transfection
MiR-196a mimics (miR-196a), miR-205 mimics (miR-205), and scrambled miRNA oligonucleotides (miR-NC) were purchased from GenePharma (Shanghai, China). The complementary DNA (cDNA) of GAS5 was chemically synthesized and cloned into the KpnI and BamHI sites of pcDNA expression vector (Invitrogen), namely, pcDNA-GAS5. Cells (1 × 10 4 cells/well) were plated onto six-well plates and cultured for 24 h prior to transfection. Then, miRNA mimics and plasmids were transfected into cells using Lipofectamine 2000 (Invitrogen). The cells were collected 48 h after transfection and applied for further functional analysis of target genes.
Quantitative reverse transcription polymerase chain reaction
Total RNA from obtained tissues and cultured cells was isolated using TRIzol reagent (Invitrogen). For the detection of GAS5 expression, total RNA (1 µg) was reverse transcribed into cDNA using PrimeScript ® RT Reagent Kit (TaKaRa, Osaka, Japan). Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was conducted using a SYBR Premix Ex Taq II Kit (Applied Biosystems, Foster City, CA, USA) on an Applied Biosystems 7500 RealTime PCR system (Applied Biosystems). For the measurement of miRNA expression, miRNA-specific cDNA was synthesized from 5 ng of total RNA using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems). The expression levels of let-7a, let-7b, let-7c, miR-101, miR-196a, and miR-205 were quantified using miRNA-specific TaqMan MiRNA Assay Kit (Applied Biosystems) on an Applied Biosystems 7500 RealTime PCR system (Applied Biosystems). The relative expression of GAS5 or miRNAs was calculated using the 2 −ΔΔCt method and normalized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and U6 small nuclear RNA (snRNA), respectively.
Cell viability assay
Cells were seeded onto 96-well plates at a density of 5000 per wells and transfected with pcDNA or pcDNA-GAS5. At 48 h after transfection, 20 µL of 5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, St. Louis, MO, USA) was added into each well to incubate for 4 h at 37°C. The supernatant was then removed and 200 µL of dimethyl sulfoxide (DMSO) was added to dissolve the precipitate. Optical density at 490 nm was measured using a microplate reader (Bio-Rad, Hercules, CA, USA).
Colony formation assay
A total of 300 transfected cells were seeded onto 12-well plates and cultured in complete media containing 10% FBS, which was replaced every 3 days. Following 11 days of incubation, the cells were fixed with 10% formaldehyde for 15 min and stained with crystal violet for 5 min. Colonies containing at least 50 cells were counted to evaluate the colony formation ability.
Transwell invasion assay
For the cell invasion assay, 24-well Transwell ™ plates with Matrigel ™ -coated membranes (8-µm pore) were used (BD Biosciences, Franklin Lakes, NJ, USA). Briefly, 4 × 10 4 cells resuspended in 200 µL of serum free RPMI-1640 medium were added into the upper chamber, and the lower chamber was filled with the same medium containing 10% FBS as a chemoattractant. After incubating for 24 h at 37°C under 5% CO 2 , non-invading cells were removed from the upper chamber by cotton-tipped swabs. Cells invading into lower chamber were fixed using cold methanol, stained with crystal violet, and counted using an inverted microscope (Olympus, Tokyo, Japan) in five random fields.
Analysis of apoptosis by flow cytometry
At 48 h post transfection, cells were collected and resuspended in binding buffer at a density of 1 × 10 6 cells/mL. The cells were labeled with Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) reagent (BD Biosciences, San Jose, CA, USA) for 15 min in the dark at room temperature. Data acquisition and analysis were performed using CellQuest software on a FACSCalibur ™ flow cytometer (BD Biosciences, San Jose, CA, USA).
Plasmid construction and dual-luciferase reporter assay
Constructs were established by inserting wild type or mutated GAS5 fragments containing binding sites of miR-196a or miR-205 into the downstream of the luciferase reporter pmirGLO (Promega, Madison, WI, USA), namely, pmirGLO-GAS5 or pmirGLO-GAS5-mut1/2. Following this, the cells were co-transfected with pmirGLO, pmir-GLO-GAS5, or pmirGLO-GAS5-mut1/2 and miR-196a, miR-205, or miR-NC. At 48 h post transfection, the luciferase intensity was determined using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions. A control vector pRL-TK (Promega) carrying Renilla luciferase gene was also co-transfected into cells for normalization of luciferase activity.
Western blot analysis
The cells were transfected with miR-196a, miR-205, or along with pcDNA or pcDNA-GAS5 and cultured for 48 h. Then, the cells were harvested and lysed in ice-cold radioimmunoprecipitation assay (RIPA) lysis buffer (Beyotime, Jiangsu, China) for 40 min. Protein concentration was quantified using an Enhanced BCA Protein Assay Kit (Beyotime). Equal amount of protein samples were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA, USA). The membranes were blocked with 5% non-fat milk for 1 h at room temperature and then probed with primary antibodies forkhead box protein O1 (FOXO1; 1:2000 dilution; Cell Signaling Technology, Beverly, MA, USA), phosphatase and tensin homolog (PTEN; 1:2000 dilution; Cell Signaling Technology), and β-action (1:5000 dilution; Sigma) for overnight at 4°C, followed by incubation with horseradish peroxidase-conjugated mouse and rabbit secondary antibody (1:2000 dilution; Abcam, Cambridge, MA, USA) for 2 h at room temperature. The signals were visualized using an enhanced chemiluminescence system (ECL ™ ; Amersham, Little Chalfont, UK) and analyzed using a FluorChem FC2 Imaging System (Alpha Innotech, San Leandro, CA, USA).
RNA immunoprecipitation
RNA immunoprecipitation (RIP) assay was conducted to determine whether GAS5 interacts with miR-196a or miR-205 in cervical cancer cells using Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore). Briefly, the cells were rinsed with phosphate-buffered saline (PBS), lysed in RIP lysis buffer, and then incubated with magnetic beads-bound human anti-Argonaute2 (Ago2) antibody (Millipore) or control normal mouse immunoglobulin G (IgG; Millipore). Afterward, the samples were incubated with proteinase K to digest protein and the immunoprecipitated RNA was isolated by QIAamp MinElut Virus Spin Kit (Qiagen, Hilden, Germany). Finally, purified RNA was analyzed by qRT-PCR to confirm the presence of the binding sites.
Tumor xenograft model in nude mice
The animal experiment was conducted strictly in accordance with a protocol approved by the Animal Care and Use Committee of Renmin Hospital of Wuhan University. The 4-week-old male athymic BALB/c nude mice, purchased from the Shanghai National Center for Laboratory Animals, Chinese Academy of Sciences, were maintained under specific pathogen-free conditions. Exponentially growing SiHa cells (1 × 10 7 ) transfected with pcDNA or pcDNA-GAS5 were suspended in PBS and subcutaneously injected into the left flank of the nude mice to establish different xenograft models (pcDNA group, n = 6; pcDNA-GAS5 group, n = 6) of cervical cancer. When tumors reached about 100 mm 3 , tumor volumes were measured every 3 days using calipers and calculated using the following formula: length × width 2 × 0.5. The mice were killed on day 21 and tumor masses were excised and weighted. The tumor tissues were finally collected for qRT-PCR analysis of miR-196a and miR-205.
Statistical analysis
All values were expressed as mean ± standard deviation (SD) from at least three independent experiments. GraphPad Prism V5.0 (GraphPad Software, Inc., La Jolla, CA, USA) software was used to determine statistical differences by using the Student's t test or one-way analysis of variance (ANOVA). p < 0.05 was considered to be statistically significant.
Results
GAS5 was downregulated in cervical cancer tissues and cell lines
To determine the function of GAS5 during tumorigenesis of cervical cancer, we first detected the expression of GAS5 in tumor tissues and adjacent normal tissues from 41 patients suffering from cervical cancers. As shown in Figure 1(a) , qRT-PCR analysis displayed significantly lower levels of GAS5 in cervical cancer tissues compared to normal tissues. Subsequently, the expression of GAS5 in cervical cancer cells was further detected by qRT-PCR. As expected, GAS5 expression was also dramatically downregulated in cervical cancer cells (SiHa, HT-3, SW756, and ME-180) compared with human normal cervix tissues (NCs; Figure 1(b) ). More interestingly, GAS5 was differentially expressed in the four cervical cancer cells. SiHa cells exhibited the lowest level of GAS5, followed by ME-180 cells. Thus, SiHa and ME-180 cells were chosen for further analysis.
Ectopic expression of GAS5 promoted tumorigenesis of cervical cancer in vitro
To confirm the functional effects of GAS5 on cervical cancer cells, we successfully established SiHa and ME-180 cells overexpressing GAS5 by transfection of pcDNA-GAS5, as presented by qRT-PCR in Figure 2 (a). Exogenetic expression of GAS5 significantly suppressed cell viability in both SiHa and ME-180 cells, as detected by MTT assay (Figure 2(b) ). Similarly, colony formation assay indicated that exogenous expression of GAS5 exhibited significantly decreased clone numbers compared with control group in SiHa and ME-180 cells (Figure 2(c) ), suggesting that GAS5 overexpression impeded growth of cervical cancer cells. Transwell invasion assay was conducted to determine the effect of GAS5 overexpression on cervical cancer cell invasiveness and the results implied that upregulation of GAS5 remarkably attenuated the number of invaded cells compared with control pcDNA-transfected cells (Figure 2(d) ). Flow cytometry analysis confirmed that transfection of pcDAN-GAS5 led to a marked increase of apoptotic rate in SiHa (Figure 2(e) ) and ME-180 (Figure 2(f) ) cells compared to pcDNA group. Together, the above findings suggested that GAS5 might exert anti-tumorigenic property in cervical cancer progression.
GAS5 overexpression downregulated the expression of miR-196a and miR-205
LncRNA has been demonstrated to act as a ceRNA for miRNA in regulating the biological functions within the cell, forming intricate regulatory networks. To investigate whether GAS5 has the similar function, online bioinformatics softwares including TargetScan, miRanda, and DIANA were used to predict the potential miRNAs. As a result, miR-196a and miR-205 were obtained as the candidate miRNAs (Figure 4(a) ). We first evaluated the effect of GAS5 on the expression of miR-196a and miR-205 in SiHa and ME-180 cells. Let-7 family (let-7a, let-7b, and let-7c) and miR-101, predicted not to be a potential target for GAS5, were selected as the internal controls. As demonstrated by qRT-PCR in Figure 3 (a) and (b), the expression of miR-196a and miR-205 was significantly depressed in pcDNA-GAS5-transfected SiHa and -ME-180 cells with respect to pcDNA group. However, no change was observed in the expression of let-7 family and miR-101 in SiHa and ME-180 cells between pcDNA-GAS5 and pcDNA group. These results revealed that GAS5 could decrease the expression levels of miR-196a and miR-205.
GAS5 functioned as a molecular sponge of miR-196a and miR-205 in cervical cancer cells
Web-based prediction system verified the existence of binding regions between GAS5 and miR-196a or miR-205 (Figure 4(a) ) To verify whether GAS5 could directly interact with miR-196a and miR-205, we constructed luciferase vectors containing wild type or mutant binding sites of GAS5 in miR-196a or miR-205 and performed luciferase reporter assay. As shown in Figure 4(b) , miR-196a or miR-205 overexpression significantly reduced the luciferase activity of pmirGLO-GAS5 reporter but had no obvious effect on their empty vectors (pmirGLO) and mutant reporters (pmirGLO-GAS5-mut1/2). It is well documented that miRNA exerts its function by miRNA ribonucleoprotein complexes (miRNPs) that contain Ago2, a key component of the RNA-induced silencing complex (RISC). 19 To examine whether GAS5 physically interacted with RISC complex and associated with miR-196a and miR-205, RIP assay was conducted using specific antibody against Ago2 protein. The results revealed that the endogenous GAS5 pull down by Ago2 was dramatically enriched for miR-196a-or miR-205-overexpressing SiHa and -ME-180 cells compared with control groups (Figure 4(c) ), suggesting that miR-196a and miR-205 are GAS5-targeting miRNAs. In addition, upregulation of GAS5 by pcDNA-GAS5 transfection markedly repressed the expression of miR-196a and miR-205 compared with pcDNA group in SiHa and ME-180 cells, while GAS5-mut(1+2) had no obvious inhibitory effect on miR-196a and miR-205 expression (Figure 4(d) ). Previous studies demonstrated that miR-196a and miR-205 functioned as oncogenic miRNAs by targeting FOXO1 20 and PTEN, 21 respectively. To explore whether GAS5 regulated the expression of FOXO1 and PTEN by sponging miR-196a and miR-205, respectively, western blot analysis was conducted to determine the protein levels of FOXO1 and PTEN in SiHa cells after transfection of miR-196a, miR-205, or in combination with pcDNA-GAS5. As illustrated in Figure 4 (e), ectopic expression of miR-196 decreased the level of FOXO1, and miR-205 upregulation reduced the expression of PTEN in SiHa cells, whereas GAS5 overexpression remarkably abolished these effects. All these results revealed that GAS5 functioned as a molecular sponge of miR-196a and miR-205 in cervical cancer.
GAS5 overexpression inhibited tumor growth in vivo by downregulating miR-196a and miR-205
To examine the biological role of GAS5 and its molecular mechanism in vivo, pcDNA-or pcDNA-GAS5-transfected SiHa cells were inoculated into nude mice to establish a xenograft model of cervical cancer. We then examined the effect of GAS5 overexpression on the expression of miR-196a and miR-205 and tumor growth in vivo. As displayed in Figure 5 (a), the expression of miR-196a and miR-205 in the pcDNA-GAS5 group was significantly downregulated compared with the pcDNA group. Forced expression of GAS5 dramatically repressed tumor growth compared to control group. Also, a remarkable decrease of tumor size and weight in the pcDNA-GAS5 group was observed compared with that in the pcDNA group ( Figure 5(c) ). These data demonstrated that GAS5 overexpression blocked tumor growth in vivo by downregulating miR-196a and miR-205.
Discussion
Cervical cancer remains to be the second most common gynecologic malignancy in the world, so it is urgent for us to find novel and effective molecular targets and further explore the underlying mechanisms to improve the clinical strategies of cervical cancer. Recently, increasing evidence has indicated that lncRNAs play important roles in the pathogenesis and development of multiple cancers including cervical cancer, through the regulation of multiple target genes involved in the progression of tumors. 22, 23 LncRNAs were demonstrated to act as either oncogenes or tumor suppressors depending on the specific circumstance. 24 In a previous study, downregulation of GAS5 was discovered to predict a poor prognosis and GAS5 was proved to function as a tumor suppressor in the cervical cancer; 15 therefore, we further investigated the molecular mechanism of GAS5 involved in cervical cancer progression.
GAS5 has been identified as a crucial regulator in tumorigenesis of various tumors. 25 In our study, we verified that GAS5 was significantly downregulated in cervical cancer tissues and cell lines. More importantly, forced expression of GAS5 significantly suppressed cell growth, invasion, and markedly induced apoptosis in cervical cancer cells, suggesting that GAS5 played a tumor suppressive role in cervical cancer. This is consistent with its anti-tumorous effect in other cancers. 26 In ovarian cancer, GAS5 was decreased in tumor tissues and indicated a poor prognosis; moreover, overexpression of GAS5 inhibited ovarian cancer cell proliferation partly via regulating cyclin D1, p21, and apoptosis protease activating factor 1 (APAF1) expression. 27 In colorectal cancer (CRC), GAS5 was commonly downregulated in CRC tissues, serum of patients, and CRC cell lines; knockdown of GAS5 promoted cell proliferation and colony formation while overexpression of GAS5 exhibited the opposite results. 28 In hepatocellular carcinoma, low expression of GAS5 indicated a poor prognosis and promoted cell proliferation, invasion, and suppressed apoptosis by negatively regulating vimentin. 29 As broadly suggested by several studies, lncRNAs finely regulate gene expression at transcriptional and posttranscriptional level. 30 It is generally believed that lncR-NAs, including GAS5, function as ceRNAs to modulate miRNA via the base pairing with miRNA response elements in cellular biological processes of tumors. [31] [32] [33] Hence, we further investigated the potential mechanism of GAS5 involved in the regulatory network of cervical cancer progression, namely, serving as "molecular sponges" to regulate miRNAs. Online bioinformatics softwares were employed to predict the potential miRNAs of GAS5, and miR-196a and miR-205 were presented to contain putative binding regions in GAS5 sequences. We first found that GAS5 could negatively regulate the expression of miR-196a and miR-205. Mechanically, it was confirmed that GAS5 acted as molecular sponges of miR-196a and miR-205, with putative miRNA response element and RISC involved in the ceRNA regulatory network, as demonstrated by luciferase reporter assays and RIP. It was reported that miR-196a and miR-205 functioned as oncogenic miRNAs by targeting FOXO1 20 and PTEN, 21 respectively. More interestingly, our study demonstrated that GAS5 could regulate the expression levels of FOXO1 and PTEN by sponging miR-196a and miR-205 in cervical cancer, respectively. Similarly, GAS5 was found to induce PTEN expression through inhibiting miR-103 in endometrial cancer cells. 34 In addition, transplantation experiment further demonstrated that GAS5 overexpression suppressed tumor growth in vivo by downregulating miR-196a and miR-205.
In conclusion, we demonstrated that GAS5 was downregulated in cervical cancer tissues and cells. Mechanistically, our study indicated that GAS5 overexpression suppressed tumorigenesis of cervical cancer by downregulating miR-196a and miR-205 in vitro and in vivo, contributing to our better understanding of the pathogenesis of cervical cancer and development of lncRNAmediated clinical therapy against this disease. Therefore, GAS5 may be a potential prognostic biomarker and therapeutic target in cervical cancer, which might be exploitable in anti-cancer drug development in the future.
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